Sign inJoin waitlistJoin the waitlist

Yusuf Menda

Medical Director, PET Imaging, Radiology · Roy J. and Lucille A. Carver College of Medicine

Credentials: · · ·

History

PET Imaging · Roy J. and Lucille A. Carver College of Medicine
Present
Free Radical Metabolism and Imaging (FRMI) Program · University of Iowa Health Care Medical Center
Present
Roy J. and Lucille A. Carver College of Medicine
Present

University of Iowa Health Care Medical Center
1997–1998
Nuclear Medicine
University of Iowa Health Care Medical Center
1994–1997
University of Istanbul, Istanbul
1990–1994

Research

The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors
Pancreas · 2020 · 312 citations
The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society
Review · Pancreas · 2017 · 299 citations
Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography
Journal of Clinical Oncology · 2005 · 287 citations

Michael Graham
37 papers
David Bushnell
23 papers
SO
Sue O’Dorisio
23 papers
TO
Thomas O’Dorisio
22 papers
John Buatti
16 papers
James Howe
15 papers
MJ
Malik Juweid
9 papers
Daniel Kahn
7 papers
Joseph Dillon
7 papers
KD
Kenneth Dornfeld
7 papers
Andrew Bellizzi
6 papers
GF
Gerry Funk
6 papers

Grants

Targeting CXCR4 and Redox Metabolism for Alpha Particle Therapy of Pulmonary Neuroendocrine Tumors and Carcinomas
National Cancer Institute · R01
PI · $628.3K · University of Iowa
2026–2031
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
PI · $4.3M · University of Iowa
2025–2030
Alpha-Particle Emitter Peptide Receptor Targeted Radionuclide Therapy for Neuroendocrine Tumors
National Cancer Institute · R01
Contact PI · $2.5M · University of Iowa
2019–2026
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
Project lead · $1.6M · University of Iowa
2015–2022

Clinical trials

A Safety Study of 212Pb-Pentixather Radioligand Therapy
Principal investigator · Not yet recruiting · Early phase 1
Yusuf Menda
2026–2030
Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors
Principal investigator · Active not recruiting · Early phase 1
Yusuf Menda
2017–2030
Positron Emission Mammography With Fluorothymidine (FLT) to Evaluate Treatment Response to Chemotherapy in Breast Cancer
Principal investigator · Withdrawn
University of Iowa
2009–2010
F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients
Principal investigator · Completed · Phase 2
University of Iowa
2008–2014